228 related articles for article (PubMed ID: 11024124)
1. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Virol; 2000 Nov; 74(21):9964-71. PubMed ID: 11024124
[TBL] [Abstract][Full Text] [Related]
2. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
[TBL] [Abstract][Full Text] [Related]
3. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
Babcock GJ; Hochberg D; Thorley-Lawson AD
Immunity; 2000 Oct; 13(4):497-506. PubMed ID: 11070168
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
5. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.
Babcock GJ; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12250-5. PubMed ID: 11035774
[TBL] [Abstract][Full Text] [Related]
6. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
[TBL] [Abstract][Full Text] [Related]
7. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines.
Laytragoon-Lewin N; Chen F; Avila-Carino J; Klein G; Mellstedt H
Int J Cancer; 1997 May; 71(3):345-9. PubMed ID: 9139865
[TBL] [Abstract][Full Text] [Related]
11. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
12. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
13. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
14. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
15. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
16. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
17. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
[TBL] [Abstract][Full Text] [Related]
18. Changes in Tonsil B Cell Phenotypes and EBV Receptor Expression in Children Under 5-Years-Old.
Wohlford EM; Baresel PC; Wilmore JR; Mortelliti AJ; Coleman CB; Rochford R
Cytometry B Clin Cytom; 2018 Mar; 94(2):291-301. PubMed ID: 28885784
[TBL] [Abstract][Full Text] [Related]
19. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.
Miyashita EM; Yang B; Babcock GJ; Thorley-Lawson DA
J Virol; 1997 Jul; 71(7):4882-91. PubMed ID: 9188550
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood.
Chen H; Smith P; Ambinder RF; Hayward SD
Blood; 1999 May; 93(9):3026-32. PubMed ID: 10216099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
